Action of lycopene in prostate cancer: a literature review

Authors

DOI:

https://doi.org/10.33448/rsd-v11i17.38687

Keywords:

Prostate cancer; Lycopene; Tomato; Carotenoids.

Abstract

Introduction: Prostate cancer is the second most common cancer in men. It is a neoplasm focused on the prostate gland. Risk factors are: age over 50 years, genetic factors, eating habits, environmental factors, smoking, alcohol consumption, obesity and African Americans. Carotenoids are compounds that neutralize free radicals and reactive oxygen species. They are found in fruits such as strawberries, tomatoes and papaya. Therefore, the human being is incapable of producing such compounds, being necessary the ingestion of these foods. Lycopene can inhibit the development of cancer cells, decreasing their carcinogenesis through direct mechanisms such as interruption of cell cycles, apoptosis and modulatory signaling. Objective: To investigate the efficacy of the antioxidant action of lycopene on inflammatory and tumor necrosis factors associated with prostate cancer. Methodology: This is an integrative literature review of a descriptive and qualitative nature. Conducted through research platforms such as PubMed and Scielo, books and official websites such as the Instituto Nacional do Câncer and Instituto Oncoguia. Results: 20 articles were selected, 10 of which were experimental, comprising a sample of 288 individuals and 10 systematic reviews and meta-analyses. Conclusion: Lycopene in the men's diet proved to be beneficial. It acts by inhibiting the activation of carcinogenesis, proliferation, angiogenesis, invasion and metastases, blocking tumor cell cycle progression and apoptotic induction through changes in several signaling pathways. However, studies are necessary to better elucidate the bioavailability of lycopene and its mechanism of action in the human body.

References

Antunes, Sofia Raquel Neves. (2017). Propriedades fitoquímicas do licopeno: efeito preventivo no cancro da próstata. 2017. Disponível em: https://comum.rcaap.pt/bitstream/10400.26/20231/1/Antunes_Sofia_Raquel_Neves.pdf. Acesso em: 10 out. 2021.

Applegate, Catherine C. (2019). Can Lycopene Impact the Androgen Axis in Prostate Cancer?: A Systematic Review of Cell Culture and Animal Studies. 2019. Disponível em: https://pubmed.ncbi.nlm.nih.gov/30875962/#:~:text=Dietary%20intake%20of%20tomato%20 and,signaling%20in%20normal%20prostate%20tissue.. Acesso em: 10 mar. 2022.

Borel, P., Desmarchelier, C., Dumont, et al. (2016). Dietary calcium impairs tomato lycopene bioavailability in healthy humans. British Journal of Nutrition, 116(12), 2091-2096. doi:10.1017/S0007114516004335

Bôto, Edilayne Gomes et al. (2019). Lycopene and Prostate Cancer Prevention: An Integrative Review. Disponível em: https://www.thiemeconnect.com/products/ejournals/pdf/10.1055/s-0039-1693734.pdf. Acesso em: 10 out. 2021.

Carnauba, Renata Alves; Nicastro, Humberto. (2015). Carotenoides. In: Seixas, Daniela. Compostos Bioativos dos Alimentos. Brasil: Vp Editora. p. 30-46.

Chen, Jinyao. (2013). Lycopene/tomato consumption and the risk of prostate cancer: a systematic review and meta-analysis of prospective studies. Disponível em: https://pubmed.ncbi.nlm.nih.gov/23883692/. Acesso em: 10 mar. 2022.

Chen, Ping et al. (2015). Lycopene and Risk of Prostate Cancer: A Systematic Review and Meta-Analysis. 2015. Disponível em: https://pubmed.ncbi.nlm.nih.gov/26287411/. Acesso em: 10 mar. 2022.

Costa JAP, Matias AGC. (2014). Câncer de próstata e a relação quimiopreventiva do licopeno: revisão sistematizada. Revista Tempus – Actas de Saúde Coletiva 2014; 8:223– 238

Datta, Mridul. (2013). Dietary and serum lycopene levels in prostate cancer patients undergoing intensity-modulated radiation therapy. Disponível em: https://pubmed.ncbi.nlm.nih.gov/24180552/. Acesso em: 10 mar. 2022.

Gann, Peter H et al. (2015) A Phase II Randomized Trial of Lycopene-Rich Tomato Extract Among Men with High-Grade Prostatic Intraepithelial Neoplasia. 2015. Disponível em: https://pubmed.ncbi.nlm.nih.gov/26422197/. Acesso em: 10 mar. 2022.

Grainger, Elizabeth M, et al. (2015). A comparison of plasma and prostate lycopene in response to typical servings of tomato soup, sauce or juice in men before prostatectomy. Disponível em: https://pubmed.ncbi.nlm.nih.gov/26202168/. Acesso em: 10 mar. 2022.

Inca. (2020). Estimativa: introdução. Disponível em:

https://www.inca.gov.br/estimativa/introducao. Acesso em: 06 out. 2021

Li D, Chen L, Zhao W, et al. (2016). MicroRNA-let-7f-1 is induced by lycopene and inhibits cell proliferation and triggers apoptosis in prostate cancer. Mol Med Rep 2016;13(03):2708–2714.

Li, Ni et al. (2021). Tomato and lycopene and multiple health outcomes: Umbrella review.

Disponível em: https://pubmed.ncbi.nlm.nih.gov/33131949/. Acesso em: 10 mar. 2022.

Mariani, Simone et al. (2014). Low prostate concentration of lycopene is associated with development of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia. Disponível em: https://pubmed.ncbi.nlm.nih.gov/24451130/. Acesso em: 10 mar. 2022.

Martí, Raúl. (2016). Tomato as a Source of Carotenoids and Polyphenols Targeted to Cancer Prevention. 2016. Disponível em:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931623/. Acesso em: 10 out. 2021.

Mirahmadi, Mahdi et al. (2020). Potential inhibitory effect of lycopene on prostate cancer. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32768949/. Acesso em: 06 nov. 2021.

Oliveira, Daniela da Silva. (2012). Vitamina C, carotenoides, fenólicos totais e atividade antioxidante de goiaba, manga e mamão procedentes da Ceasa do Estado de Minas Gerais. Disponível em: https://nuppre.ufsc.br/files/2014/04/2011-Oliveira-et-al.pdf. Acesso em: 18 out. 2021.

Park, Eunyoung et al. (2013). Diet adherence dynamics and physiological responses to a tomato product whole-food intervention in African-American men. Disponível em: https://pubmed.ncbi.nlm.nih.gov/23200261/. Acesso em: 10 mar. 2022.

Paur, Ingvild, et al. (2016). Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA. 2016. Disponível em: https://pubmed.ncbi.nlm.nih.gov/27406859/. Acesso em: 10 mar. 2022.

Pernar, Claire H. et al. (2018). The Epidemiology of Prostate Cancer. Disponível em: https://pubmed.ncbi.nlm.nih.gov/29311132/. Acesso em: 06 out. 2021.

Qiu X, Yuan Y, Vaishnav A, et al. (2013). Effects of lycopene on protein expression in human primary prostatic epithelial cells.

Cancer Prev Res (Phila) 2013;6(05):419–427

Sharifi-Zahabi, Elham et al. (2022). The effect of lycopene supplement from different sources on prostate specific antigen (PSA): A systematic review and meta-analysis of randomized controlled trials. 2022. Disponível em: https://pubmed.ncbi.nlm.nih.gov/35031434/. Acesso em: 10 mar. 2022.

Trejo-solís C, Jose Pedraza-Chaverrí J, Torres-Ramos M, et al. (2013). Multiple Molecular and Cellular Mechanisms of Action of Lycopene in Cancer Inhibition. Evid Based Complement Alternat Med 2013;21(2013):705121

Zhang, Xin. Lycopene can reduce prostate-specific antigen velocity in a phase II clinical study in Chinese population. 2014. Disponível em: https://pubmed.ncbi.nlm.nih.gov/24890168/#:~:text=No%20toxic%20side%20effect%20was, velocity%20in%20this%20study%20group. Acesso em: 10 mar. 2022.

Published

18/12/2022

How to Cite

FERREIRA, A. P. M. .; CORDEIRO, F. M. .; CORREA, G. A. .; GITTE, P. H. de M. .; JANKO, P. H. C. .; VILELA, L. R. R. . Action of lycopene in prostate cancer: a literature review. Research, Society and Development, [S. l.], v. 11, n. 17, p. e12111738687, 2022. DOI: 10.33448/rsd-v11i17.38687. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/38687. Acesso em: 25 dec. 2024.

Issue

Section

Health Sciences